Oct
2026
Fiera Milano, Italy
Visit us
stand 9A50, Machinery & Equipment
Zone
Syntegon Technology
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Germany
-
On CPHI since:2020
-
Certificates:4
-
Employees:5000+
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 9A50, Machinery & Equipment
Products Featured at CPHI Milan 2026
-
Product Syntegon´s Solutions for the pharmaceutical industry
· Process technology
· Solid dosage forms
· Liquid dosage forms
· Inspection technology
· Secondary packaging... -
Product Syntegon solutions for the pharmaceutical industry
Process technology
Liquid fill/finish
Solid dosage formsNutraceutical solutions
Medtech solutions
Customer services
Pharma services
Qualification and vaildation
As a full-service provider, we take
responsibility for fully integ... -
Product Syntegon SVP Process System
The highly modular and standardized system solution providing the highest degree of flexibility in both the layout of the customer’s room concept and the configuration of the production units themselves. Over 70 pre-tested functional modules are available to process batch sizes from 13 to 3,000 liters. -
Product Launch: microBatch & Synexio
Dream big. Start small. Versynta microBatch is a small machine with high output and flexibility. The gloveless working is a big step in the realization of robotic competence at a very small scale. Fast batch-to-batch changeovers, minimized product loss and a fully integrated machine and isolator are t... -
Product The new way of continuous direct compression
The trend towards small batches continues in the manufacture of oral solids dosage forms. The Xelum platform offers continuous solutions from fluid bed granulation to direct compression. Get a presentation of our new way of continuous direct compression at CPhI in Barcelona.
Syntegon Technology GmbH Resources (1)
-
Video Syntegon Flexitab XL tablet pressing machine
As a single punch machine, the FlexiTab XL is designed for early stage tablet development, the production of clinical trial batches, the screening of powders and granules for subsequent product development, as well as the assessment of multi-layer drug dosing and characterization of powder properties.A large range of tablet and oblong shapes can be produced (using up to three APIs) and analyzed with the enhanced DAQ software.In cooperation with RÖLTGEN GmbH & Co. KG.




